DOPAMINE HYDROCHLORIDE

DOPAMINE HYDROCHLORIDE was reported 3802 times

DOPAMINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HARLEQUIN SKIN REACTION 3 0.2000
1 ENZYME INDUCTION 7 0.1458
2 HEPATOSPLENOMEGALY NEONATAL 5 0.1190
3 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE 4 0.1053
4 POSTHAEMORRHAGIC HYDROCEPHALUS 4 0.0690
5 CIRCULATORY FAILURE NEONATAL 4 0.0678
6 PANTOEA AGGLOMERANS INFECTION 5 0.0649
7 NEONATAL MULTI-ORGAN FAILURE 3 0.0600
8 SYSTOLIC ANTERIOR MOTION OF MITRAL VALVE 5 0.0595
9 LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 20 0.0575
10 NEONATAL PNEUMOTHORAX 3 0.0545
11 OBSTRUCTIVE SHOCK 5 0.0459
12 ALLERGIC MYOCARDITIS 3 0.0441
13 PULMONARY HAEMORRHAGE NEONATAL 4 0.0435
14 NEWBORN PERSISTENT PULMONARY HYPERTENSION 12 0.0427
15 FEVER NEONATAL 5 0.0382
16 EXTUBATION 3 0.0370
17 PH BODY FLUID ABNORMAL 5 0.0360
18 DEVICE PACING ISSUE 3 0.0353
19 POSTOPERATIVE RENAL FAILURE 5 0.0345
20 NEONATAL CARDIAC FAILURE 3 0.0333
21 NEONATAL ANURIA 3 0.0316
22 ANAPHYLACTOID SYNDROME OF PREGNANCY 3 0.0312
23 RENAL ISCHAEMIA 17 0.0311
24 PO2 INCREASED 15 0.0296
25 ATELECTASIS NEONATAL 3 0.0278
26 RETINOPATHY OF PREMATURITY 15 0.0271
27 DRUG-DEVICE INTERACTION 3 0.0270
28 RENAL FAILURE NEONATAL 6 0.0270
29 CSF WHITE BLOOD CELL COUNT INCREASED 5 0.0262
30 ENTEROBACTER PNEUMONIA 4 0.0256
31 PCO2 INCREASED 17 0.0239
32 PHAEOCHROMOCYTOMA CRISIS 5 0.0236
33 DECOMPENSATED HYPOTHYROIDISM 3 0.0222
34 THROMBOCYTOPENIA NEONATAL 9 0.0214
35 HYPERTROPHIC CARDIOMYOPATHY 33 0.0213
36 HYPERDYNAMIC LEFT VENTRICLE 5 0.0203
37 RENAL VESSEL DISORDER 4 0.0190
38 DRY GANGRENE 12 0.0189
39 INFUSION SITE INJURY 3 0.0170
40 INCISION SITE PAIN 20 0.0170
41 CARDIAC ASSISTANCE DEVICE USER 6 0.0160
42 HIV VIRAEMIA 3 0.0143
43 ATRIOVENTRICULAR DISSOCIATION 3 0.0140
44 HYPERBILIRUBINAEMIA NEONATAL 8 0.0137
45 NEUROMUSCULAR BLOCK PROLONGED 5 0.0136
46 RED BLOOD CELLS URINE POSITIVE 13 0.0134
47 BRASH SYNDROME 18 0.0128
48 LIMB AMPUTATION 5 0.0126
49 INTRAVENTRICULAR HAEMORRHAGE NEONATAL 6 0.0123
50 BLOOD LUTEINISING HORMONE INCREASED 3 0.0122
51 PULMONARY CALCIFICATION 5 0.0121
52 MEAN ARTERIAL PRESSURE DECREASED 3 0.0119
53 BLOOD PH DECREASED 20 0.0117
54 COAGULATION TEST ABNORMAL 9 0.0117
55 SYSTOLIC DYSFUNCTION 12 0.0114
56 DELAYED GRAFT FUNCTION 8 0.0113
57 PNEUMATOSIS 5 0.0112
58 BRONCHOPULMONARY DYSPLASIA 9 0.0112
59 NEONATAL HYPOTENSION 4 0.0109
60 DISTRIBUTIVE SHOCK 24 0.0106
61 JUGULAR VEIN DISTENSION 6 0.0106
62 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 4 0.0105
63 HYPOPERFUSION 11 0.0105
64 NODAL ARRHYTHMIA 9 0.0105
65 BLOOD BICARBONATE DECREASED 19 0.0100
66 NECROTISING ENTEROCOLITIS NEONATAL 4 0.0099
67 DYSBIOSIS 8 0.0097
68 CANDIDA TEST POSITIVE 4 0.0096
69 ISCHAEMIC HEPATITIS 13 0.0095
70 DIABETES INSIPIDUS 22 0.0091
71 PLEOCYTOSIS 5 0.0086
72 PROPOFOL INFUSION SYNDROME 6 0.0085
73 ANAEMIA NEONATAL 4 0.0083
74 HEART SOUNDS ABNORMAL 6 0.0080
75 BRADYCARDIA NEONATAL 10 0.0079
76 NEONATAL RESPIRATORY FAILURE 4 0.0079
77 ELECTROCARDIOGRAM QRS COMPLEX SHORTENED 3 0.0078
78 SKIN SENSITISATION 8 0.0077
79 BLOOD FOLLICLE STIMULATING HORMONE INCREASED 3 0.0077
80 HYPERMAGNESAEMIA 5 0.0077
81 MYOGLOBINURIA 4 0.0075
82 ACUTE LEFT VENTRICULAR FAILURE 5 0.0074
83 OXYGEN SATURATION ABNORMAL 21 0.0074
84 CARDIOGENIC SHOCK 106 0.0074
85 NEONATAL HYPOXIA 6 0.0073
86 NECROTISING MYOSITIS 6 0.0069
87 SYMPTOM MASKED 5 0.0069
88 INTRAVENTRICULAR HAEMORRHAGE 17 0.0068
89 OPERATIVE HAEMORRHAGE 3 0.0067
90 PERSISTENT FOETAL CIRCULATION 4 0.0066
91 ABDOMINAL COMPARTMENT SYNDROME 4 0.0063
92 OLIGURIA 39 0.0063
93 HEPATOSPLENOMEGALY 16 0.0062
94 SEPSIS NEONATAL 5 0.0062
95 SPUTUM CULTURE POSITIVE 5 0.0062
96 ACUTE PRERENAL FAILURE 7 0.0060
97 CLONUS 16 0.0058
98 HEPATIC HAEMORRHAGE 5 0.0058
99 HAEMODYNAMIC INSTABILITY 43 0.0056
100 MUCOSAL EROSION 5 0.0055
101 PERICARDIAL HAEMORRHAGE 12 0.0055
102 LIP EROSION 4 0.0055
103 ACINETOBACTER INFECTION 6 0.0055
104 VASOSPASM 5 0.0054
105 CARDIAC HYPERTROPHY 6 0.0054
106 SERRATIA INFECTION 4 0.0054
107 PULMONARY HAEMORRHAGE 42 0.0054
108 INTRAVASCULAR HAEMOLYSIS 3 0.0054
109 HEPATIC CONGESTION 5 0.0053
110 MOTOR DEVELOPMENTAL DELAY 3 0.0052
111 MEDIASTINITIS 3 0.0052
112 VENTRICULAR FIBRILLATION 57 0.0051
113 ANURIA 44 0.0051
114 LABORATORY TEST INTERFERENCE 4 0.0051
115 MULTI-ORGAN FAILURE 88 0.0051
116 ELECTROENCEPHALOGRAM ABNORMAL 16 0.0051
117 DEATH NEONATAL 7 0.0050
118 DIAPHRAGMATIC PARALYSIS 3 0.0050
119 HEPATORENAL FAILURE 3 0.0050
120 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 13 0.0050
121 INFANTILE APNOEA 4 0.0049
122 VASOPLEGIA SYNDROME 8 0.0049
123 PERITONEAL DIALYSIS 4 0.0048
124 TROPONIN I INCREASED 8 0.0048
125 NODAL RHYTHM 7 0.0048
126 SHOCK 109 0.0047
127 NECROTISING COLITIS 6 0.0047
128 ENTEROCOCCAL BACTERAEMIA 5 0.0047
129 PROCEDURAL HYPOTENSION 4 0.0047
130 ENTEROCOCCUS TEST POSITIVE 3 0.0046
131 VENTRICULAR TACHYCARDIA 75 0.0045
132 STRESS CARDIOMYOPATHY 26 0.0045
133 SINUS ARREST 7 0.0045
134 ACIDOSIS 34 0.0044
135 RIGHT VENTRICULAR HYPERTROPHY 4 0.0044
136 BRAIN HERNIATION 13 0.0043
137 CEREBRAL VENTRICLE DILATATION 5 0.0043
138 HYPERCAPNIA 13 0.0043
139 RESPIRATORY ALKALOSIS 7 0.0043
140 ANAL HAEMORRHAGE 12 0.0043
141 BILIRUBIN CONJUGATED INCREASED 10 0.0043
142 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 6 0.0043
143 ACUTE LUNG INJURY 5 0.0042
144 MYOCARDIAL NECROSIS MARKER INCREASED 7 0.0042
145 TELANGIECTASIA 4 0.0041
146 ESCHAR 3 0.0041
147 CARDIOPULMONARY FAILURE 16 0.0041
148 HYPERLACTACIDAEMIA 11 0.0041
149 DRUG-DISEASE INTERACTION 3 0.0041
150 DISSEMINATED INTRAVASCULAR COAGULATION 57 0.0040
151 MATERNAL EXPOSURE DURING DELIVERY 4 0.0040
152 PRINZMETAL ANGINA 4 0.0040
153 HYPERNATRAEMIA 20 0.0040
154 URINE OUTPUT DECREASED 35 0.0040
155 ATRIOVENTRICULAR BLOCK SECOND DEGREE 12 0.0040
156 TORSADE DE POINTES 31 0.0039
157 METHAEMOGLOBINAEMIA 9 0.0039
158 BLOOD UREA INCREASED 65 0.0039
159 MULTIPLE ORGAN DYSFUNCTION SYNDROME 109 0.0038
160 LIVEDO RETICULARIS 8 0.0038
161 ELECTROMECHANICAL DISSOCIATION 3 0.0038
162 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 19 0.0037
163 RIGHT VENTRICULAR FAILURE 26 0.0037
164 PERIPHERAL ISCHAEMIA 15 0.0037
165 RIGHT VENTRICULAR DYSFUNCTION 4 0.0036
166 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 12 0.0036
167 NEUTROPHIL COUNT INCREASED 37 0.0036
168 PERITONEAL HAEMORRHAGE 5 0.0036
169 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 4 0.0036
170 PULSELESS ELECTRICAL ACTIVITY 15 0.0036
171 LEFT VENTRICULAR DYSFUNCTION 24 0.0036
172 RESPIRATORY ACIDOSIS 14 0.0036
173 BRAIN DEATH 11 0.0036
174 MYOCARDIAL INJURY 4 0.0036
175 KLEBSIELLA SEPSIS 4 0.0035
176 COMPLICATIONS OF TRANSPLANTED KIDNEY 8 0.0035
177 GANGRENE 21 0.0035
178 FOETAL DEATH 18 0.0035
179 AORTIC THROMBOSIS 4 0.0035
180 RENAL INFARCT 5 0.0035
181 HEPARIN-INDUCED THROMBOCYTOPENIA 17 0.0034
182 SPLENIC INFARCTION 6 0.0034
183 METABOLIC ACIDOSIS 110 0.0034
184 ATRIOVENTRICULAR BLOCK COMPLETE 23 0.0034
185 CARDIAC FAILURE ACUTE 22 0.0033
186 VENTRICULAR ARRHYTHMIA 12 0.0033
187 BLOOD PRESSURE IMMEASURABLE 5 0.0033
188 PNEUMOPERITONEUM 6 0.0032
189 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 7 0.0032
190 DELAYED RECOVERY FROM ANAESTHESIA 3 0.0032
191 LABYRINTHITIS 8 0.0032
192 INHIBITORY DRUG INTERACTION 5 0.0032
193 COR PULMONALE 3 0.0031
194 LEFT ATRIAL DILATATION 4 0.0031
195 HAEMOTHORAX 9 0.0031
196 CARDIAC VENTRICULAR THROMBOSIS 4 0.0031
197 RESPIRATORY DISORDER NEONATAL 5 0.0031
198 VENTRICULAR DYSFUNCTION 8 0.0031
199 CONTINUOUS HAEMODIAFILTRATION 3 0.0031
200 STAPHYLOCOCCAL SEPSIS 15 0.0030
201 ANION GAP INCREASED 4 0.0030
202 BRAIN HYPOXIA 3 0.0030
203 ENTEROBACTER INFECTION 5 0.0030
204 HYPOGONADISM 3 0.0030
205 CARDIAC TAMPONADE 14 0.0029
206 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 15 0.0029
207 HEPATIC NECROSIS 11 0.0029
208 TOXIC EPIDERMAL NECROLYSIS 44 0.0029
209 SINUS BRADYCARDIA 28 0.0029
210 DILATATION VENTRICULAR 6 0.0029
211 PERIPHERAL ARTERY THROMBOSIS 4 0.0028
212 PERIPHERAL ARTERY OCCLUSION 4 0.0028
213 RETROPERITONEAL HAEMORRHAGE 7 0.0028
214 NEUROMYOPATHY 3 0.0028
215 VENTRICULAR HYPOKINESIA 9 0.0028
216 STUPOR 9 0.0028
217 COMA SCALE ABNORMAL 8 0.0028
218 LYMPHOCYTE COUNT DECREASED 48 0.0027
219 PUPILLARY REFLEX IMPAIRED 5 0.0027
220 PULMONARY HYPERTENSION 55 0.0026
221 ISCHAEMIC CARDIOMYOPATHY 8 0.0026
222 DIASTOLIC DYSFUNCTION 8 0.0026
223 NEPHROGENIC ANAEMIA 12 0.0026
224 ISCHAEMIC CEREBRAL INFARCTION 3 0.0026
225 INFUSION SITE INFECTION 6 0.0026
226 HYPOVOLAEMIA 15 0.0026
227 HYPOTONIA NEONATAL 4 0.0026
228 CARDIAC ARREST 208 0.0025
229 BRADYCARDIA 133 0.0025
230 ESCHERICHIA TEST POSITIVE 3 0.0025
231 HYPOVOLAEMIC SHOCK 12 0.0025
232 COAGULOPATHY 41 0.0025
233 CARDIOVASCULAR INSUFFICIENCY 4 0.0025
234 VASCULAR STENT THROMBOSIS 5 0.0025
235 HYPOALBUMINAEMIA 19 0.0024
236 BLOOD MAGNESIUM DECREASED 21 0.0024
237 HYPERURICAEMIA 10 0.0024
238 GENERALISED OEDEMA 30 0.0024
239 EUGLYCAEMIC DIABETIC KETOACIDOSIS 10 0.0024
240 INFLAMMATORY MARKER INCREASED 12 0.0024
241 HYPERBILIRUBINAEMIA 25 0.0024
242 TACHYARRHYTHMIA 6 0.0024
243 BLOOD ALBUMIN DECREASED 19 0.0024
244 HYPERPARATHYROIDISM SECONDARY 6 0.0024
245 SINUS TACHYCARDIA 34 0.0024
246 VASODILATATION 6 0.0024
247 SPLEEN DISORDER 4 0.0024
248 INTESTINAL ISCHAEMIA 13 0.0024
249 HEPATITIS FULMINANT 7 0.0024
250 FOETAL DISTRESS SYNDROME 5 0.0024
251 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 9 0.0024
252 POOR PERIPHERAL CIRCULATION 10 0.0023
253 ACUTE RESPIRATORY FAILURE 45 0.0023
254 BLOOD CHLORIDE DECREASED 6 0.0023
255 LYMPHOCYTOSIS 5 0.0023
256 DRUG CLEARANCE DECREASED 3 0.0023
257 CIRCULATORY COLLAPSE 39 0.0023
258 MYOCARDIAL ISCHAEMIA 26 0.0023
259 CARDIOACTIVE DRUG LEVEL INCREASED 3 0.0023
260 BLOOD LACTIC ACID INCREASED 12 0.0023
261 AORTIC VALVE STENOSIS 4 0.0022
262 VENTRICULAR EXTRASYSTOLES 23 0.0022
263 PROTEIN URINE PRESENT 11 0.0022
264 CALCIPHYLAXIS 4 0.0022
265 GASTROINTESTINAL PERFORATION 9 0.0022
266 LACTIC ACIDOSIS 70 0.0022
267 RENAL INJURY 64 0.0022
268 ACUTE RESPIRATORY DISTRESS SYNDROME 38 0.0021
269 CULTURE URINE POSITIVE 3 0.0021
270 STATUS EPILEPTICUS 24 0.0021
271 RESPIRATORY DEPRESSION 26 0.0021
272 HYPOPROTEINAEMIA 4 0.0021
273 CEREBELLAR HAEMORRHAGE 3 0.0021
274 ARTERIAL DISORDER 4 0.0021
275 HYPOREFLEXIA 4 0.0021
276 KIDNEY TRANSPLANT REJECTION 10 0.0021
277 RENAL FAILURE CHRONIC 16 0.0021
278 STAPHYLOCOCCAL BACTERAEMIA 9 0.0021
279 ARTERIAL THROMBOSIS 4 0.0021
280 PNEUMONIA CYTOMEGALOVIRAL 4 0.0021
281 GASTROINTESTINAL NECROSIS 6 0.0021
282 SEPTIC SHOCK 89 0.0020
283 RENAL TUBULAR NECROSIS 20 0.0020
284 PNEUMONIA STAPHYLOCOCCAL 4 0.0020
285 ILEUS PARALYTIC 9 0.0020
286 LOW BIRTH WEIGHT BABY 16 0.0020
287 RENAL FAILURE ACUTE 85 0.0020
288 HYPOTENSION 397 0.0020
289 FIBRIN D DIMER INCREASED 7 0.0020
290 RENAL HAEMORRHAGE 4 0.0020
291 HYPOXIA 69 0.0020
292 ISCHAEMIA 9 0.0020
293 BLOOD CALCIUM DECREASED 22 0.0020
294 GRAFT VERSUS HOST DISEASE 14 0.0019
295 EXTRAVASATION 8 0.0019
296 BRAIN NATRIURETIC PEPTIDE INCREASED 6 0.0019
297 BRONCHOPULMONARY ASPERGILLOSIS 15 0.0019
298 SKIN NECROSIS 10 0.0019
299 STAPHYLOCOCCUS TEST POSITIVE 4 0.0019
300 RESPIRATORY FAILURE 138 0.0019
301 PULSE ABSENT 9 0.0019
302 SUPRAVENTRICULAR TACHYCARDIA 18 0.0019
303 AREFLEXIA 5 0.0019
304 FEAR 50 0.0019
305 ANTICONVULSANT DRUG LEVEL INCREASED 3 0.0019
306 PROTHROMBIN TIME PROLONGED 11 0.0018
307 BRADYARRHYTHMIA 3 0.0018
308 COLONIC POLYP 3 0.0018
309 RETROPERITONEAL HAEMATOMA 4 0.0018
310 PSEUDOMEMBRANOUS COLITIS 4 0.0018
311 FEAR OF DEATH 4 0.0018
312 BLOOD PRESSURE SYSTOLIC DECREASED 8 0.0018
313 EXPOSURE VIA BREAST MILK 7 0.0018
314 DUODENAL ULCER HAEMORRHAGE 5 0.0017
315 ARTERIOSPASM CORONARY 7 0.0017
316 PULMONARY CONGESTION 23 0.0017
317 TRIGEMINAL NEURALGIA 7 0.0017
318 PANCREATITIS NECROTISING 4 0.0017
319 BLOOD CHLORIDE INCREASED 3 0.0017
320 PULMONARY ARTERIAL HYPERTENSION 25 0.0017
321 EXTREMITY NECROSIS 3 0.0017
322 PULMONARY OEDEMA 77 0.0017
323 PARTIAL SEIZURES 9 0.0017
324 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 3 0.0017
325 NEONATAL RESPIRATORY DISTRESS SYNDROME 6 0.0017
326 BREAST CYST 3 0.0017
327 JUGULAR VEIN THROMBOSIS 3 0.0017
328 CYTOMEGALOVIRUS TEST POSITIVE 3 0.0017
329 CREPITATIONS 5 0.0017
330 MITRAL VALVE INCOMPETENCE 19 0.0017
331 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 16 0.0017
332 BLOOD CULTURE POSITIVE 5 0.0017
333 CARDIO-RESPIRATORY ARREST 69 0.0016
334 AORTIC VALVE INCOMPETENCE 7 0.0016
335 RENAL IMPAIRMENT 138 0.0016
336 AMYLASE INCREASED 6 0.0016
337 CARDIOMYOPATHY 24 0.0016
338 CARDIAC FAILURE 127 0.0016
339 KLEBSIELLA INFECTION 8 0.0016
340 THERAPY NON-RESPONDER 71 0.0016
341 BLOOD LACTATE DEHYDROGENASE INCREASED 25 0.0016
342 ORTHOPNOEA 5 0.0016
343 ATRIOVENTRICULAR BLOCK 12 0.0016
344 HAEMODIALYSIS 13 0.0015
345 BACTERIAL SEPSIS 5 0.0015
346 BLOOD PRESSURE DECREASED 102 0.0015
347 URINE OUTPUT INCREASED 4 0.0015
348 VENOUS THROMBOSIS 6 0.0015
349 MULTI-ORGAN DISORDER 3 0.0015
350 BACTERAEMIA 18 0.0015
351 THERAPEUTIC AGENT TOXICITY 5 0.0015
352 RENAL FAILURE 198 0.0015
353 ANHEDONIA 39 0.0015
354 BRADYPNOEA 4 0.0015
355 CLOSTRIDIAL INFECTION 5 0.0015
356 HEPATIC FUNCTION ABNORMAL 55 0.0015
357 CARDIOMEGALY 18 0.0015
358 HICCUPS 12 0.0015
359 ESCHERICHIA INFECTION 12 0.0015
360 ECCHYMOSIS 10 0.0015
361 LEFT VENTRICULAR FAILURE 5 0.0015
362 CAPILLARY LEAK SYNDROME 3 0.0014
363 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 4 0.0014
364 FLUID OVERLOAD 21 0.0014
365 CONGESTIVE CARDIOMYOPATHY 6 0.0014
366 ATRIAL TACHYCARDIA 3 0.0014
367 TACHYPNOEA 19 0.0014
368 HYPERPHOSPHATAEMIA 3 0.0014
369 LUNG CANCER METASTATIC 4 0.0014
370 ATRIAL FLUTTER 11 0.0014
371 CLOSTRIDIUM TEST POSITIVE 3 0.0014
372 ELECTROCARDIOGRAM T WAVE INVERSION 3 0.0014
373 SHOCK HAEMORRHAGIC 11 0.0013
374 HISTIOCYTOSIS HAEMATOPHAGIC 4 0.0013
375 BRAIN OEDEMA 17 0.0013
376 ATELECTASIS 13 0.0013
377 BACTERIAL TEST POSITIVE 3 0.0013
378 SEPSIS 150 0.0013
379 CALCINOSIS 3 0.0013
380 HYPERKALAEMIA 47 0.0013
381 URINE ANALYSIS ABNORMAL 4 0.0013
382 GASTROINTESTINAL HYPOMOTILITY 3 0.0013
383 HEPATOCELLULAR DAMAGE 3 0.0013
384 PROTEIN TOTAL DECREASED 5 0.0013
385 LEUKOCYTOSIS 24 0.0013
386 KOUNIS SYNDROME 3 0.0013
387 ACUTE KIDNEY INJURY 201 0.0013
388 ELECTROCARDIOGRAM QT PROLONGED 47 0.0013
389 ENCEPHALOPATHY 32 0.0013
390 HYPOKALAEMIA 60 0.0013
391 HEPATIC FAILURE 39 0.0013
392 DEPRESSED LEVEL OF CONSCIOUSNESS 51 0.0013
393 INFUSION SITE EXTRAVASATION 8 0.0013
394 HYPOTHERMIA 13 0.0013
395 DRUG LEVEL BELOW THERAPEUTIC 7 0.0013
396 PANCREATITIS CHRONIC 3 0.0013
397 INTRA-ABDOMINAL HAEMORRHAGE 3 0.0013
398 PATENT DUCTUS ARTERIOSUS 5 0.0013
399 PULMONARY ALVEOLAR HAEMORRHAGE 7 0.0012
400 RHABDOMYOLYSIS 52 0.0012
401 ENTEROCOCCAL INFECTION 6 0.0012
402 PORTAL VEIN THROMBOSIS 4 0.0012
403 THROMBOSIS IN DEVICE 4 0.0012
404 BLOOD PRESSURE DIASTOLIC DECREASED 9 0.0012
405 BODY TEMPERATURE DECREASED 12 0.0012
406 HYPOPHOSPHATAEMIA 9 0.0012
407 HIGH DENSITY LIPOPROTEIN DECREASED 4 0.0012
408 CATHETER SITE HAEMORRHAGE 3 0.0012
409 WHITE BLOOD CELL COUNT INCREASED 46 0.0012
410 RESPIRATORY DISTRESS 33 0.0012
411 ASCITES 35 0.0012
412 HYPERTHERMIA 9 0.0012
413 ENDOCARDITIS 6 0.0012
414 MYDRIASIS 15 0.0012
415 LEFT VENTRICULAR HYPERTROPHY 5 0.0012
416 HEPATIC FIBROSIS 4 0.0012
417 HAEMOLYSIS 9 0.0012
418 PERIPHERAL COLDNESS 16 0.0012
419 ATRIOVENTRICULAR BLOCK FIRST DEGREE 5 0.0012
420 HYPOPNOEA 4 0.0012
421 HYPOMAGNESAEMIA 16 0.0011
422 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 63 0.0011
423 EXFOLIATIVE RASH 3 0.0011
424 HAEMORRHAGE INTRACRANIAL 17 0.0011
425 MYOCARDITIS 13 0.0011
426 BLOOD CREATININE INCREASED 74 0.0011
427 TRICUSPID VALVE INCOMPETENCE 9 0.0011
428 JAUNDICE CHOLESTATIC 4 0.0011
429 HYPERGLYCAEMIA 41 0.0011
430 ANAESTHETIC COMPLICATION 3 0.0011
431 BRAIN INJURY 11 0.0011
432 COMA 52 0.0011
433 ALANINE AMINOTRANSFERASE INCREASED 67 0.0011
434 MOUTH HAEMORRHAGE 8 0.0011
435 UNRESPONSIVE TO STIMULI 28 0.0011
436 ON AND OFF PHENOMENON 6 0.0011
437 FREEZING PHENOMENON 4 0.0011
438 INTENTIONAL OVERDOSE 69 0.0011
439 PNEUMOTHORAX 17 0.0011
440 ACUTE PULMONARY OEDEMA 6 0.0011
441 PLEURAL EFFUSION 65 0.0011
442 PREMATURE BABY 32 0.0011
443 ACUTE LYMPHOCYTIC LEUKAEMIA 3 0.0011
444 PSEUDOMONAS INFECTION 9 0.0010
445 MENINGITIS 7 0.0010
446 C-REACTIVE PROTEIN INCREASED 38 0.0010
447 EXERCISE TOLERANCE DECREASED 6 0.0010
448 CARDIAC MURMUR 9 0.0010
449 ENTEROCOLITIS 6 0.0010
450 DYSPNOEA AT REST 3 0.0010
451 EJECTION FRACTION DECREASED 16 0.0010
452 VENOOCCLUSIVE LIVER DISEASE 5 0.0010
453 HYPERVOLAEMIA 5 0.0010
454 ORGANISING PNEUMONIA 5 0.0010
455 CEREBRAL ATROPHY 4 0.0010
456 HYPERAMMONAEMIA 5 0.0010
457 METABOLIC ENCEPHALOPATHY 3 0.0010
458 CEREBROVASCULAR DISORDER 3 0.0010
459 CORONARY ARTERY STENOSIS 5 0.0010
460 ORGAN FAILURE 4 0.0010
461 STEVENS-JOHNSON SYNDROME 22 0.0010
462 BLOOD POTASSIUM INCREASED 16 0.0010
463 ASPARTATE AMINOTRANSFERASE INCREASED 52 0.0010
464 POLYURIA 8 0.0010
465 GENERALISED TONIC-CLONIC SEIZURE 16 0.0010
466 AORTIC DISSECTION 4 0.0010
467 MULTIPLE INJURIES 6 0.0010
468 ACUTE HEPATIC FAILURE 13 0.0010
469 SPUTUM DISCOLOURED 9 0.0009
470 BUNDLE BRANCH BLOCK LEFT 4 0.0009
471 CLOSTRIDIUM DIFFICILE COLITIS 10 0.0009
472 THROMBOTIC MICROANGIOPATHY 9 0.0009
473 HYPERLIPIDAEMIA 11 0.0009
474 NORMAL NEWBORN 5 0.0009
475 DIALYSIS 13 0.0009
476 HEPATOMEGALY 9 0.0009
477 ACUTE MYOCARDIAL INFARCTION 27 0.0009
478 OTITIS MEDIA 3 0.0009
479 LUNG INFILTRATION 8 0.0009
480 ARTERIOSCLEROSIS CORONARY ARTERY 6 0.0009
481 MENTAL STATUS CHANGES 25 0.0009
482 OLIGOHYDRAMNIOS 3 0.0009
483 CYTOMEGALOVIRUS VIRAEMIA 4 0.0009
484 INJURY 63 0.0009
485 BK VIRUS INFECTION 3 0.0009
486 BLOOD BILIRUBIN INCREASED 24 0.0009
487 VASCULAR DEVICE INFECTION 4 0.0009
488 PREMATURE DELIVERY 14 0.0009
489 HAEMOGLOBIN INCREASED 4 0.0009
490 BRONCHOPNEUMONIA 3 0.0009
491 ACUTE GRAFT VERSUS HOST DISEASE 4 0.0009
492 UROSEPSIS 8 0.0009
493 PERICARDIAL EFFUSION 20 0.0009
494 METABOLIC DISORDER 5 0.0009
495 ELECTROLYTE IMBALANCE 10 0.0009
496 EXTRASYSTOLES 6 0.0009
497 ANAPHYLACTIC SHOCK 22 0.0009
498 NECROTISING FASCIITIS 3 0.0009
499 PULMONARY TOXICITY 6 0.0008
500 HAEMORRHAGE SUBCUTANEOUS 3 0.0008
501 HYPOCALCAEMIA 16 0.0008
502 DIVERTICULUM 6 0.0008
503 HAEMORRHAGIC DIATHESIS 3 0.0008
504 POST PROCEDURAL COMPLICATION 16 0.0008
505 ALTERED STATE OF CONSCIOUSNESS 18 0.0008
506 TOXICITY TO VARIOUS AGENTS 136 0.0008
507 MALNUTRITION 9 0.0008
508 HYDRONEPHROSIS 6 0.0008
509 PNEUMONIA ASPIRATION 20 0.0008
510 TACHYCARDIA 71 0.0008
511 RESPIRATORY ARREST 22 0.0008
512 TUMOUR LYSIS SYNDROME 7 0.0008
513 UNEVALUABLE EVENT 60 0.0008
514 TROPONIN INCREASED 6 0.0008
515 DYSLIPIDAEMIA 4 0.0008
516 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 4 0.0008
517 CHOLESTASIS 15 0.0008
518 POST PROCEDURAL HAEMORRHAGE 9 0.0008
519 CARDIAC FAILURE CONGESTIVE 61 0.0008
520 HAEMATOCRIT DECREASED 15 0.0008
521 THROMBOCYTOPENIA 84 0.0008
522 AZOTAEMIA 3 0.0008
523 DRUG INTERACTION 119 0.0007
524 HAEMOGLOBIN DECREASED 77 0.0007
525 TRANSPLANT REJECTION 6 0.0007
526 CANDIDIASIS 3 0.0007
527 ADRENAL INSUFFICIENCY 9 0.0007
528 PLATELET COUNT DECREASED 79 0.0007
529 INTERNATIONAL NORMALISED RATIO DECREASED 3 0.0007
530 POSTOPERATIVE WOUND INFECTION 5 0.0007
531 CEREBRAL INFARCTION 18 0.0007
532 INTERNATIONAL NORMALISED RATIO INCREASED 21 0.0007
533 DECUBITUS ULCER 6 0.0007
534 HYDROCEPHALUS 4 0.0007
535 BLOOD CREATINE PHOSPHOKINASE INCREASED 21 0.0007
536 ACUTE CORONARY SYNDROME 6 0.0007
537 ILEUS 9 0.0007
538 FOOT DEFORMITY 8 0.0007
539 STREPTOCOCCAL INFECTION 4 0.0007
540 NECROSIS 4 0.0007
541 ANGIOPATHY 4 0.0007
542 INTESTINAL PERFORATION 8 0.0007
543 CHOLECYSTITIS ACUTE 4 0.0007
544 CARDIAC FAILURE CHRONIC 3 0.0007
545 NEUROLOGICAL SYMPTOM 4 0.0007
546 CEREBRAL HAEMORRHAGE 25 0.0007
547 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 5 0.0007
548 OXYGEN SATURATION DECREASED 39 0.0007
549 BLOOD URIC ACID INCREASED 4 0.0007
550 RALES 4 0.0007
551 SUBARACHNOID HAEMORRHAGE 7 0.0007
552 PRODUCT LABEL CONFUSION 4 0.0007
553 BLOOD ALKALINE PHOSPHATASE INCREASED 17 0.0007
554 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 6 0.0007
555 GAMMA-GLUTAMYLTRANSFERASE INCREASED 15 0.0007
556 PLEURISY 4 0.0007
557 DRUG LEVEL INCREASED 11 0.0007
558 BLOOD THYROID STIMULATING HORMONE DECREASED 3 0.0007
559 END STAGE RENAL DISEASE 12 0.0007
560 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 4 0.0007
561 HYPONATRAEMIA 37 0.0007
562 PNEUMONIA BACTERIAL 6 0.0007
563 BUNDLE BRANCH BLOCK RIGHT 3 0.0007
564 FOETAL EXPOSURE DURING PREGNANCY 53 0.0007
565 GLOMERULAR FILTRATION RATE DECREASED 8 0.0007
566 DEVICE RELATED INFECTION 10 0.0006
567 DEMENTIA 18 0.0006
568 HAEMATURIA 22 0.0006
569 APNOEA 5 0.0006
570 HAEMORRHAGIC STROKE 5 0.0006
571 BONE MARROW FAILURE 13 0.0006
572 ASPIRATION 7 0.0006
573 ELECTROCARDIOGRAM ABNORMAL 5 0.0006
574 CYANOSIS 10 0.0006
575 PRODUCT PACKAGING ISSUE 6 0.0006
576 OBSTRUCTIVE AIRWAYS DISORDER 7 0.0006
577 PANCREATITIS ACUTE 14 0.0006
578 DRUG ERUPTION 11 0.0006
579 GOUT 11 0.0006
580 ASPERGILLUS INFECTION 4 0.0006
581 PANCREATIC DISORDER 3 0.0006
582 OEDEMA 33 0.0006
583 CAESAREAN SECTION 7 0.0006
584 EOSINOPHIL COUNT INCREASED 5 0.0006
585 ATRIAL FIBRILLATION 58 0.0006
586 UPPER GASTROINTESTINAL HAEMORRHAGE 10 0.0006
587 MELAENA 13 0.0006
588 BLOOD IRON DECREASED 7 0.0006
589 SEIZURE 68 0.0006
590 GENERAL PHYSICAL HEALTH DETERIORATION 68 0.0006
591 ANAEMIA 112 0.0006
592 FAILURE TO THRIVE 3 0.0006
593 LIVER INJURY 14 0.0006
594 ARRHYTHMIA 27 0.0006
595 THERMAL BURN 4 0.0006
596 CONDITION AGGRAVATED 171 0.0006
597 CARDIOTOXICITY 5 0.0006
598 SUBDURAL HAEMATOMA 8 0.0006
599 DERMATITIS BULLOUS 4 0.0006
600 CYTOMEGALOVIRUS INFECTION 9 0.0005
601 HEART RATE DECREASED 19 0.0005
602 HEPATOTOXICITY 12 0.0005
603 BACTERIAL INFECTION 10 0.0005
604 NEPHROPATHY TOXIC 6 0.0005
605 PERITONITIS 11 0.0005
606 SUICIDE ATTEMPT 32 0.0005
607 NEUTROPHILIA 3 0.0005
608 HYPERTONIA 3 0.0005
609 GASTRIC HAEMORRHAGE 6 0.0005
610 HALLUCINATION, VISUAL 11 0.0005
611 LIVER FUNCTION TEST ABNORMAL 15 0.0005
612 NEUTROPHIL COUNT DECREASED 21 0.0005
613 ABDOMINAL DISTENSION 53 0.0005
614 ISCHAEMIC STROKE 9 0.0005
615 MUSCLE RIGIDITY 6 0.0005
616 CYTOKINE RELEASE SYNDROME 10 0.0005
617 LIVER DISORDER 22 0.0005
618 CONJUNCTIVITIS 9 0.0005
619 STAPHYLOCOCCAL INFECTION 16 0.0005
620 HYPERTHYROIDISM 7 0.0005
621 PANCYTOPENIA 27 0.0005
622 FEBRILE NEUTROPENIA 32 0.0005
623 EPISTAXIS 36 0.0005
624 HEMIPLEGIA 4 0.0005
625 DRUG INEFFECTIVE 626 0.0005
626 CONVULSION 27 0.0005
627 SEROTONIN SYNDROME 9 0.0005
628 RESPIRATORY DISORDER 14 0.0005
629 DYSKINESIA 19 0.0005
630 GASTROINTESTINAL HAEMORRHAGE 39 0.0005
631 HAEMATOMA 12 0.0005
632 BLOOD PRESSURE SYSTOLIC INCREASED 9 0.0005
633 HYPOGAMMAGLOBULINAEMIA 3 0.0005
634 PULMONARY EMBOLISM 43 0.0005
635 PNEUMONIA 146 0.0005
636 EXPOSURE DURING PREGNANCY 28 0.0005
637 TRANSAMINASES INCREASED 10 0.0004
638 RASH MACULO-PAPULAR 10 0.0004
639 CHRONIC KIDNEY DISEASE 34 0.0004
640 MYELOSUPPRESSION 16 0.0004
641 BODY TEMPERATURE INCREASED 9 0.0004
642 SCIATICA 7 0.0004
643 INFARCTION 3 0.0004
644 MATERNAL EXPOSURE DURING PREGNANCY 39 0.0004
645 LETHARGY 25 0.0004
646 CARDIOVASCULAR DISORDER 11 0.0004
647 GRAND MAL CONVULSION 4 0.0004
648 BLOOD POTASSIUM DECREASED 13 0.0004
649 DELIRIUM 15 0.0004
650 DISORIENTATION 17 0.0004
651 DRUG RESISTANCE 11 0.0004
652 SPLENOMEGALY 5 0.0004
653 DUODENAL ULCER 3 0.0004
654 BLOOD URINE PRESENT 8 0.0004
655 NEUTROPENIC SEPSIS 3 0.0004
656 CHOLECYSTITIS 5 0.0004
657 GASTRITIS 11 0.0004
658 LOSS OF CONSCIOUSNESS 53 0.0004
659 NO THERAPEUTIC RESPONSE 5 0.0004
660 PYREXIA 141 0.0004
661 HYPOTHYROIDISM 13 0.0004
662 LOWER GASTROINTESTINAL HAEMORRHAGE 3 0.0004
663 HYPERCALCAEMIA 5 0.0004
664 EMOTIONAL DISTRESS 49 0.0004
665 ORTHOSTATIC HYPOTENSION 7 0.0004
666 HYPOTONIA 4 0.0004
667 PNEUMOCYSTIS JIROVECII PNEUMONIA 4 0.0004
668 HEART RATE IRREGULAR 9 0.0004
669 BLOOD TRIGLYCERIDES INCREASED 7 0.0004
670 MATERNAL DRUGS AFFECTING FOETUS 3 0.0004
671 CONGENITAL ANOMALY 3 0.0004
672 COGNITIVE DISORDER 18 0.0004
673 THROMBOSIS 31 0.0004
674 DEEP VEIN THROMBOSIS 25 0.0004
675 INTESTINAL OBSTRUCTION 14 0.0004
676 DECREASED ACTIVITY 4 0.0004
677 PROTEINURIA 7 0.0004
678 PNEUMONITIS 10 0.0004
679 CLOSTRIDIUM DIFFICILE INFECTION 8 0.0004
680 OVERDOSE 79 0.0004
681 CHOLELITHIASIS 12 0.0004
682 RENAL DISORDER 17 0.0004
683 HAEMORRHAGE 38 0.0004
684 CORONARY ARTERY DISEASE 11 0.0004
685 PRESCRIBED OVERDOSE 7 0.0004
686 HYPERTENSIVE CRISIS 4 0.0004
687 PANCREATITIS 19 0.0004
688 HAEMOPTYSIS 10 0.0004
689 HAEMATEMESIS 9 0.0004
690 NERVOUS SYSTEM DISORDER 11 0.0004
691 BLOOD PRESSURE ABNORMAL 7 0.0004
692 HYPOGLYCAEMIA 17 0.0004
693 PARALYSIS 5 0.0003
694 TREATMENT NONCOMPLIANCE 19 0.0003
695 UPPER RESPIRATORY TRACT INFECTION 16 0.0003
696 HYPERTENSION 73 0.0003
697 GROIN PAIN 3 0.0003
698 IMMUNOSUPPRESSION 3 0.0003
699 COVID-19 PNEUMONIA 4 0.0003
700 DISEASE PROGRESSION 40 0.0003
701 URINARY INCONTINENCE 10 0.0003
702 HAEMOLYTIC ANAEMIA 3 0.0003
703 OFF LABEL USE 291 0.0003
704 LIMB INJURY 9 0.0003
705 PALLOR 9 0.0003
706 INJECTION SITE EXTRAVASATION 4 0.0003
707 MEDICATION ERROR 18 0.0003
708 PHARYNGITIS 4 0.0003
709 HEPATIC STEATOSIS 6 0.0003
710 DELUSION 5 0.0003
711 LUNG INFECTION 5 0.0003
712 HEPATIC ENCEPHALOPATHY 3 0.0003
713 DIARRHOEA HAEMORRHAGIC 3 0.0003
714 ACUTE MYELOID LEUKAEMIA 5 0.0003
715 ABORTION INDUCED 3 0.0003
716 BLOOD SODIUM DECREASED 6 0.0003
717 RED BLOOD CELL COUNT DECREASED 9 0.0003
718 TREATMENT FAILURE 26 0.0003
719 OEDEMA PERIPHERAL 38 0.0003
720 METASTASES TO CENTRAL NERVOUS SYSTEM 4 0.0003
721 PSYCHOTIC DISORDER 9 0.0003
722 DISABILITY 6 0.0003
723 RESTLESSNESS 11 0.0003
724 PERICARDITIS 5 0.0003
725 FACE OEDEMA 5 0.0003
726 HEMIPARESIS 5 0.0003
727 DRUG LEVEL DECREASED 3 0.0003
728 BLOOD GLUCOSE INCREASED 55 0.0003
729 CARDIAC DISORDER 27 0.0003
730 DEVICE OCCLUSION 4 0.0003
731 LYMPHOPENIA 4 0.0003
732 MYOCARDIAL INFARCTION 49 0.0003
733 BRONCHOSPASM 4 0.0003
734 LEUKOPENIA 14 0.0003
735 HEREDITARY ANGIOEDEMA 3 0.0003
736 CELLULITIS 14 0.0003
737 OSTEOMYELITIS 5 0.0003
738 HYPOKINESIA 4 0.0003
739 PRODUCTIVE COUGH 13 0.0003
740 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 7 0.0003
741 AGRANULOCYTOSIS 5 0.0003
742 WHITE BLOOD CELL COUNT DECREASED 29 0.0003
743 PRODUCT USE ISSUE 50 0.0003
744 ECONOMIC PROBLEM 4 0.0003
745 ANXIETY 75 0.0003
746 CHOLECYSTECTOMY 3 0.0003
747 MUSCULOSKELETAL STIFFNESS 23 0.0003
748 METASTASES TO LUNG 3 0.0003
749 DRUG-INDUCED LIVER INJURY 8 0.0003
750 NEUROLEPTIC MALIGNANT SYNDROME 3 0.0003
751 HALLUCINATION 19 0.0003
752 DIABETES MELLITUS 19 0.0002
753 MENTAL IMPAIRMENT 6 0.0002
754 DEHYDRATION 33 0.0002
755 TASTE DISORDER 5 0.0002
756 MUSCULAR WEAKNESS 28 0.0002
757 URINARY TRACT INFECTION 42 0.0002
758 METASTASES TO BONE 4 0.0002
759 CONFUSIONAL STATE 39 0.0002
760 NEEDLE ISSUE 7 0.0002
761 DYSPNOEA 136 0.0002
762 FUNGAL INFECTION 8 0.0002
763 SKIN DISCOLOURATION 11 0.0002
764 DERMATITIS 5 0.0002
765 CANDIDA INFECTION 4 0.0002
766 MUSCLE ATROPHY 3 0.0002
767 FLUID RETENTION 12 0.0002
768 OSTEOARTHRITIS 10 0.0002
769 VOMITING 110 0.0002
770 HEART RATE INCREASED 23 0.0002
771 BLISTER 13 0.0002
772 RESPIRATORY TRACT INFECTION 6 0.0002
773 NEUROTOXICITY 4 0.0002
774 DRUG ADMINISTRATION ERROR 7 0.0002
775 METASTASES TO LIVER 4 0.0002
776 INTERSTITIAL LUNG DISEASE 11 0.0002
777 CHEST DISCOMFORT 23 0.0002
778 ABDOMINAL PAIN 52 0.0002
779 DRUG TOXICITY 3 0.0002
780 SYNCOPE 22 0.0002
781 CORONARY ARTERY OCCLUSION 3 0.0002
782 MOVEMENT DISORDER 7 0.0002
783 AGITATION 16 0.0002
784 COORDINATION ABNORMAL 3 0.0002
785 STOMATITIS 13 0.0002
786 TUBULOINTERSTITIAL NEPHRITIS 4 0.0002
787 FEELING HOT 13 0.0002
788 CHEST PAIN 39 0.0002
789 URINARY RETENTION 7 0.0002
790 HYPERHIDROSIS 27 0.0002
791 RECTAL HAEMORRHAGE 9 0.0002
792 ANGINA PECTORIS 6 0.0002
793 PULMONARY FIBROSIS 4 0.0002
794 BLOOD PRESSURE FLUCTUATION 5 0.0002
795 DIARRHOEA 133 0.0002
796 COMPLETED SUICIDE 17 0.0002
797 ASTHENIA 76 0.0002
798 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
799 PRODUCT USE IN UNAPPROVED INDICATION 50 0.0002
800 APHASIA 6 0.0002
801 HYPOPHAGIA 5 0.0002
802 HEPATITIS 5 0.0002
803 SKIN ULCER 5 0.0002
804 BLOOD CHOLESTEROL INCREASED 9 0.0002
805 JOINT STIFFNESS 5 0.0002
806 MOUTH ULCERATION 4 0.0002
807 DEPRESSION 43 0.0002
808 CHILLS 22 0.0002
809 DYSARTHRIA 7 0.0002
810 FAECES DISCOLOURED 4 0.0002
811 GAIT DISTURBANCE 35 0.0002
812 HAEMATOCHEZIA 10 0.0002
813 ANAPHYLACTIC REACTION 10 0.0002
814 MOBILITY DECREASED 13 0.0002
815 THERAPEUTIC RESPONSE UNEXPECTED 8 0.0002
816 CHROMATURIA 4 0.0002
817 ABNORMAL BEHAVIOUR 7 0.0002
818 FLATULENCE 10 0.0002
819 HEPATIC ENZYME INCREASED 12 0.0002
820 PAIN 108 0.0002
821 INFLAMMATION 9 0.0002
822 FALL 58 0.0002
823 HERPES ZOSTER 10 0.0002
824 EOSINOPHILIA 3 0.0002
825 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
826 COLD SWEAT 3 0.0002
827 WHEEZING 10 0.0002
828 DECREASED APPETITE 39 0.0002
829 CEREBROVASCULAR ACCIDENT 28 0.0002
830 CONTRAINDICATED PRODUCT ADMINISTERED 5 0.0002
831 DEATH 142 0.0002
832 BONE DISORDER 3 0.0002
833 EPILEPSY 5 0.0002
834 HYPOACUSIS 7 0.0002
835 PALPITATIONS 19 0.0002
836 EMOTIONAL DISORDER 5 0.0002
837 NEUTROPENIA 22 0.0002
838 MENTAL DISORDER 7 0.0002
839 AGGRESSION 8 0.0002
840 HEAD INJURY 5 0.0002
841 BLOOD PRESSURE INCREASED 24 0.0002
842 DRUG PRESCRIBING ERROR 3 0.0002
843 CONSTIPATION 34 0.0002
844 HIP FRACTURE 5 0.0002
845 RASH GENERALISED 4 0.0002
846 SOMNOLENCE 31 0.0002
847 CHOKING 3 0.0002
848 ORAL HERPES 3 0.0002
849 NERVOUSNESS 8 0.0002
850 SEDATION 4 0.0002
851 SPEECH DISORDER 8 0.0002
852 INFLUENZA 17 0.0002
853 INFECTION 22 0.0002
854 JAUNDICE 4 0.0001
855 TYPE 2 DIABETES MELLITUS 5 0.0001
856 OCULAR HYPERAEMIA 7 0.0001
857 FEELING COLD 4 0.0001
858 WITHDRAWAL SYNDROME 6 0.0001
859 LYMPHADENOPATHY 5 0.0001
860 PAIN IN JAW 4 0.0001
861 LIVER FUNCTION TEST INCREASED 3 0.0001
862 SWELLING 13 0.0001
863 DRUG EFFECT INCOMPLETE 5 0.0001
864 PANIC ATTACK 5 0.0001
865 DYSURIA 5 0.0001
866 WEIGHT INCREASED 30 0.0001
867 DYSPNOEA EXERTIONAL 5 0.0001
868 COUGH 37 0.0001
869 ERYTHEMA 27 0.0001
870 DEVICE MALFUNCTION 9 0.0001
871 INSOMNIA 34 0.0001
872 NAUSEA 101 0.0001
873 BALANCE DISORDER 11 0.0001
874 TREMOR 21 0.0001
875 RASH ERYTHEMATOUS 6 0.0001
876 DIABETIC KETOACIDOSIS 3 0.0001
877 NASOPHARYNGITIS 23 0.0001
878 OSTEONECROSIS OF JAW 3 0.0001
879 VIRAL INFECTION 4 0.0001
880 GAIT INABILITY 4 0.0001
881 ADVERSE EVENT 11 0.0001
882 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
883 DRUG EXPOSURE DURING PREGNANCY 4 0.0001
884 CATARACT 7 0.0001
885 NEUROPATHY PERIPHERAL 11 0.0001
886 DIPLOPIA 3 0.0001
887 DEVICE LEAKAGE 5 0.0001
888 DISCOMFORT 7 0.0001
889 DIZZINESS 56 0.0001
890 GASTROINTESTINAL DISORDER 10 0.0001
891 WRONG TECHNIQUE IN DRUG USAGE PROCESS 4 0.0001
892 UNDERDOSE 8 0.0001
893 DEVICE DELIVERY SYSTEM ISSUE 3 0.0001
894 NEPHROLITHIASIS 5 0.0001
895 DRUG ABUSE 9 0.0001
896 BRONCHITIS 8 0.0001
897 AMNESIA 7 0.0001
898 DYSPHAGIA 10 0.0001
899 VISUAL IMPAIRMENT 13 0.0001
900 HYPERSOMNIA 3 0.0001
901 DYSSTASIA 3 0.0001
902 PLASMA CELL MYELOMA 4 0.0001
903 LUNG DISORDER 5 0.0001
904 GASTROOESOPHAGEAL REFLUX DISEASE 8 0.0001
905 BLINDNESS 4 0.0001
906 SINUSITIS 10 0.0001
907 LUNG NEOPLASM MALIGNANT 4 0.0001
908 LIMB DISCOMFORT 3 0.0001
909 POLLAKIURIA 4 0.0001
910 MUSCULOSKELETAL PAIN 5 0.0001
911 DISTURBANCE IN ATTENTION 5 0.0001
912 SWELLING FACE 6 0.0001
913 INTENTIONAL PRODUCT MISUSE 8 0.0001
914 IMPAIRED HEALING 3 0.0001
915 FATIGUE 71 0.0001
916 ANGIOEDEMA 4 0.0001
917 LIP SWELLING 3 0.0001
918 NECK PAIN 5 0.0001
919 DEVICE ISSUE 8 0.0001
920 THROAT IRRITATION 4 0.0001
921 INJECTION SITE ERYTHEMA 11 0.0001
922 FLUSHING 9 0.0001
923 PAIN IN EXTREMITY 26 0.0001
924 ABDOMINAL PAIN UPPER 18 0.0001
925 NEOPLASM PROGRESSION 3 0.0001
926 NASAL CONGESTION 5 0.0001
927 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
928 DISEASE RECURRENCE 4 0.0001
929 MULTIPLE SCLEROSIS 4 0.0001
930 NO ADVERSE EVENT 15 0.0001
931 RASH 36 0.0001
932 CRYING 3 0.0001
933 THERAPEUTIC RESPONSE DECREASED 5 0.0001
934 MYALGIA 14 0.0001
935 ACCIDENTAL OVERDOSE 3 0.0001
936 MEMORY IMPAIRMENT 11 0.0001
937 COVID-19 14 0.0001
938 FEELING ABNORMAL 19 0.0001
939 RHINORRHOEA 5 0.0001
940 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
941 SUICIDAL IDEATION 7 0.0001
942 INFUSION RELATED REACTION 5 0.0001
943 ABORTION SPONTANEOUS 3 0.0001
944 OSTEOPOROSIS 3 0.0001
945 ABDOMINAL DISCOMFORT 12 0.0001
946 SLEEP DISORDER 5 0.0001
947 THERAPY INTERRUPTED 5 0.0001
948 BACK PAIN 16 0.0001
949 MALAISE 30 0.0001
950 WEIGHT DECREASED 19 0.0001
951 DYSGEUSIA 5 0.0001
952 ADVERSE DRUG REACTION 6 0.0001
953 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
954 VERTIGO 4 0.0001
955 HYPERSENSITIVITY 12 0.0001
956 ARTHRITIS 5 0.0001
957 DEVICE DIFFICULT TO USE 4 0.0001
958 HYPOAESTHESIA 9 0.0001
959 ARTHRALGIA 25 0.0001
960 HEADACHE 37 0.0001
961 MALIGNANT NEOPLASM PROGRESSION 6 0.0001
962 PARAESTHESIA 9 0.0001
963 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
964 DRUG WITHDRAWAL SYNDROME 5 0.0001
965 DEPRESSED MOOD 3 0.0001
966 DRUG EFFECT DECREASED 3 0.0001
967 ARTHROPATHY 3 0.0001
968 INCORRECT DOSE ADMINISTERED 12 0.0001
969 MIGRAINE 5 0.0001
970 PERIPHERAL SWELLING 8 0.0001
971 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 10 0.0000
972 DRY MOUTH 4 0.0000
973 MUSCLE SPASMS 9 0.0000
974 SKIN EXFOLIATION 4 0.0000
975 PRURITUS 18 0.0000
976 INJECTION SITE PRURITUS 3 0.0000
977 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8 0.0000
978 ASTHMA 5 0.0000
979 VISION BLURRED 6 0.0000
980 INJECTION SITE REACTION 3 0.0000
981 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
982 CONTUSION 4 0.0000
983 DRUG INTOLERANCE 4 0.0000
984 HOT FLUSH 3 0.0000
985 INJECTION SITE SWELLING 3 0.0000
986 ILLNESS 4 0.0000
987 INJECTION SITE HAEMORRHAGE 3 0.0000
988 URTICARIA 6 0.0000
989 JOINT SWELLING 4 0.0000
990 OROPHARYNGEAL PAIN 3 0.0000
991 PRODUCT QUALITY ISSUE 4 0.0000
992 HOSPITALISATION 4 0.0000
993 DRUG DEPENDENCE 4 0.0000
994 DRUG DOSE OMISSION 3 0.0000
995 PRODUCT DOSE OMISSION ISSUE 5 0.0000
996 INJECTION SITE PAIN 4 0.0000